|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.315 USD | -3.77% |
|
-18.11% | -58.70% |
| 30/06 | Forte Biosciences, Inc.(NasdaqCM:FBRX) added to Russell 3000E Index | CI |
| 30/06 | Forte Biosciences, Inc.(NasdaqCM:FBRX) added to Russell Microcap Index | CI |
| Capitalization | 12Cr 10Cr 9.43Cr 8.79Cr 16Cr 1.01TCr 18Cr 114.37Cr 43Cr 475.86Cr 44Cr 43Cr 1.74TCr | P/E ratio 2025 * |
-2.38x | P/E ratio 2026 * | -2.92x |
|---|---|---|---|---|---|
| Enterprise value | 12Cr 10Cr 9.43Cr 8.79Cr 16Cr 1.01TCr 18Cr 114.37Cr 43Cr 475.86Cr 44Cr 43Cr 1.74TCr | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
18.51% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Forte Biosciences, Inc.
More recommendations
More press releases
| 1 day | -3.77% | ||
| 1 week | -18.11% | ||
| Current month | -27.46% | ||
| 1 month | -24.23% | ||
| 3 months | +27.79% | ||
| 6 months | -39.87% | ||
| Current year | -58.70% |
| 1 week | 9.12 |  | 11.25 |
| 1 month | 9.12 | | 19.63 |
| Current year | 4.9 | | 25.97 |
| 1 year | 4.11 | | 28.68 |
| 3 years | 4.11 | | 34.5 |
| 5 years | 4.11 | | 1,349.75 |
| 10 years | 4.11 | | 1,349.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Wagner
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Anthony Riley
DFI | Director of Finance/CFO | 58 | 01/03/2020 |
| Chief Operating Officer | - | 01/10/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Wagner
CHM | Chairman | 57 | - |
Steven Kornfeld
BRD | Director/Board Member | 57 | 01/06/2020 |
Barbara Finck
BRD | Director/Board Member | 78 | 16/03/2022 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0% | 293,477 M€ | +1.27% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.77% | -18.11% | -35.31% | -71.58% | 12Cr | ||
| +0.76% | +0.87% | +15.64% | +34.43% | 3.47TCr | ||
| +2.80% | +16.24% | +110.50% | -22.84% | 3.14TCr | ||
| -1.18% | -2.62% | +28.29% | -31.11% | 2.77TCr | ||
| -1.03% | +9.20% | +203.54% | +2,445.95% | 2.1TCr | ||
| +0.06% | +8.68% | +39.07% | +364.42% | 1.99TCr | ||
| +10.71% | +28.81% | +248.31% | +510.50% | 1.44TCr | ||
| +4.04% | +10.12% | +150.89% | -62.93% | 1.41TCr | ||
| +1.00% | +1.86% | -22.33% | -44.03% | 1.35TCr | ||
| +0.85% | +0.48% | +101.62% | +110.41% | 1.22TCr | ||
| Average | +1.42% | +3.44% | +84.02% | +323.32% | 1.89TCr | |
| Weighted average by Cap. | +1.56% | +6.00% | +87.19% | +346.04% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -4.57Cr -3.91Cr -3.64Cr -3.39Cr -6.25Cr -391.8Cr -6.98Cr -44Cr -17Cr -183.76Cr -17Cr -17Cr -672.92Cr | -4Cr -3.43Cr -3.19Cr -2.97Cr -5.48Cr -343.26Cr -6.11Cr -39Cr -15Cr -161Cr -15Cr -15Cr -589.56Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
14
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/25/17 | 9.380 $ | -3.10% | 12,847 |
| 16/25/16 | 9.680 $ | +2.43% | 33,032 |
| 15/25/15 | 9.450 $ | -3.91% | 44,789 |
| 14/25/14 | 9.835 $ | -6.78% | 63,140 |
| 11/25/11 | 10.55 $ | -7.90% | 96,634 |
Delayed Quote Nasdaq, July 17, 2025 at 08:09 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.680USD
Average target price
45.67USD
Spread / Average Target
+371.76%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FBRX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition